Tacrus
Product Images NDC 82160-124
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Tacrus (NDC 82160-124). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Pella Pharmaceuticals Co. Ltd, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Primary Package 30 G (Primary Package.)
This is a description for an ointment with Tacrolimus Monohydrate 0.1% which comes in a 30g tube. Pella Pharmaceuticals Co. Itd. from Jordan is the manufacturer of this product. The tube has a length of 78.54 mm and EACH 16 contains Tacrolimus Monohydrate (1 mg). The ointment is for Cutaneous use only. It should be stored below 25°C and out of the reach of children. There is an enclosed leaflet that should be read before use. The rest of the text seems to indicate manufacturing guidelines and is not relevant.*
Secondary Package 10 G (Secondary Package 10)
Secondary Package 30 G (Secondary Package.)
This appears to be a medication description for "Tacrolimus Monohydrate 0.1%" for cutaneous use, manufactured by Pella Pharmaceuticals Co. Ltd in Jordan. It contains 1mg of Tacrolimus Monohydrate per 16 containers and should not be stored above 25°C. The text also includes cautionary information to read the enclosed leaflet before use and to keep out of reach of children. There are some unclear or non-English words in the text.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.